Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
July 17th, 2018
11.9K views
The differentiation of white and beige adipocytes from adipose tissue vascular progenitors bears potential for metabolic improvement in obesity. We describe protocols for a CD34+CD31+ endothelial cell isolation from human fat and for a subsequent in vitro expansion and differentiation into white and beige adipocytes. Several downstream applications are discussed.
Overview
This article discusses a method for isolating CD34+CD31+ endothelial cells from human adipose tissue, which can be differentiated into white and beige adipocytes. This technique has significant implications for understanding obesity and adipose tissue remodeling.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Metabolism
Background
- Obesity is linked to dysfunctional adipose tissue.
- Understanding adipocyte differentiation is crucial for metabolic health.
- CD34+CD31+ endothelial cells play a role in adipose tissue dynamics.
- Access to fresh human adipose tissue is often limited.
Purpose of Study
- To isolate endothelial cells from human adipose tissue.
- To differentiate these cells into white and beige adipocytes.
- To explore mechanisms affecting adipogenic responses.
Methods Used
- Collection of human omental and subcutaneous adipose tissue.
- Isolation of CD34+CD31+ endothelial cells.
- In vitro expansion of isolated cells.
- Differentiation of cells into adipocyte types.
Main Results
- Successful isolation of endothelial cells from small tissue samples.
- Demonstrated differentiation into white and beige adipocytes.
- Identified factors influencing adipogenic responses.
- Provided a visual protocol for cell isolation.
Conclusions
- This method enhances understanding of adipose tissue biology.
- It offers a practical approach for studying obesity-related mechanisms.
- Future applications may improve metabolic interventions.
Frequently Asked Questions
What is the significance of isolating CD34+CD31+ endothelial cells?
Isolating these cells helps in understanding their role in adipose tissue remodeling and obesity.
How does this method contribute to obesity research?
It allows researchers to explore the mechanisms of adipocyte differentiation and metabolic health.
What are the challenges in this method?
Access to fresh human adipose tissue can be limited, making the isolation process difficult.
What types of adipocytes can be differentiated from these cells?
The method allows for differentiation into both white and beige adipocytes.
What are the potential applications of this research?
It may lead to improved strategies for metabolic interventions in obesity.
Is visual demonstration important for this method?
Yes, visual aids can help clarify the complex isolation steps involved.
Executive Industry Relevance
This method enables biopharma R&D to interrogate adipogenic mechanisms in human adipose endothelial cells, supporting target validation for obesity therapeutics. By isolating CD34+CD31+ cells from small tissue biopsies, it provides a disease-relevant system for screening compounds that modulate white or beige adipocyte differentiation. The approach facilitates mechanistic de-risking and predictive confidence in preclinical models of adipose tissue remodeling.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of adipogenic pathways in human endothelial progenitors to validate therapeutic targets for obesity.
- Operational Value: Provides a reproducible cellular model from subcutaneous adipose tissue for target hypothesis testing.
Screening & Assay Development
- Scientific Value: Generates validated endothelial cells for screening compounds that enhance adipogenic responses toward white or beige phenotypes.
- Operational Value: Supports assay standardization using cryopreserved cells passaged up to P5-P6 with retained adipogenic capacity.
Translational & Preclinical Research
- Scientific Value: Enables donor-matched comparison of omental and subcutaneous depot responses to adipogenic induction for predictive modeling.
- Operational Value: Provides a translational biomarker-aligned system via adiponectin, CIDEA, and UCP-1 expression profiling post-differentiation.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target identification to preclinical validation by providing a human-relevant endothelial cell model for adipogenesis screening.
- Discovery Biology: Supports hypothesis testing on factors preventing robust adipogenic response during adipose tissue remodeling.
- Screening: Enables compound screening for adipogenic induction using Oil Red O staining and fluorescent lipid uptake as quantitative readouts.
- Analytics: Delivers measurable outputs including lipid accumulation, tubule formation in Matrigel, and endothelial marker validation via acetylated LDL uptake.
- Translational Research: Connects to preclinical continuity through depot-specific response variability and molecular marker expression consistent with mixed white-beige phenotypes.
- Enterprise Reuse: Establishes a reusable platform for isolating endothelial cells from small subcutaneous biopsies across multiple donors and depots.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in adipogenic mechanism de-risking through human cell-based modeling of obesity-related tissue remodeling.
- Operational Value: Standardized isolation from as little as 2–3 g of tissue with expansion over 10–14 days and cryopreservation capability.
- Strategic Value: Informs go/no-go decisions by identifying non-responder subjects for clinical trials targeting beige/brown adipocyte stimulation.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on depot-specific adipogenic response profiles.
Implementation Considerations
- Requires expertise in primary cell isolation, immunoseparation, and endothelial cell culture techniques.
- Dependent on access to fresh human adipose tissue collected during bariatric surgery and processed within two hours.
- Necessitates collagenase digestion, magnetic bead separation, and sterile filtration equipment for stromal vascular fraction processing.
- Requires adaptation considerations when applying the protocol to different adipose depots or donor variability in adipogenic response.
- Limited by the need for enzymatic digestion and multi-step separation, which may affect scalability for high-throughput screening without automation.
Biopharma FAQs
Why is null hypothesis testing important for validating adipogenic response in CD34+CD31+ cells?
Null hypothesis testing determines whether observed lipid accumulation after adipogenic induction exceeds baseline levels, confirming true differentiation rather than spontaneous variability. This statistical rigor supports target validation by distinguishing compound-induced effects from noise in preclinical screening.
How does isolating the stromal vascular fraction enable independent variable control in endothelial cell studies?
Isolating the stromal vascular fraction removes adipocytes and undigested tissue, enriching for CD34+CD31+ endothelial progenitors and minimizing confounding variables. This purification step ensures that observed adipogenic responses are attributable to the isolated cell population, supporting mechanistic de-risking in target validation.
What quantitative dependent variable measurements enable assessment of adipogenic differentiation in this model?
Quantitative measurements include Oil Red O staining for neutral lipid droplets, fluorescent uptake of acetylated LDL for endothelial identity, and real-time PCR for adiponectin, CIDEA, and UCP-1 expression. These outputs provide measurable endpoints to compare compound effects on white versus beige adipocyte differentiation.
Why are replication requirements critical for ensuring cross-functional collaboration in adipogenic screening?
Replication across multiple donors and depots (omental and subcutaneous) accounts for biological variability in adipogenic response, ensuring results are robust and generalizable. This supports reliable data sharing between discovery, preclinical, and clinical teams for go/no-go decisions in obesity therapeutic development.
What statistical analysis capabilities are required before implementing this method in a screening pipeline?
Implementation requires capability for comparing lipid accumulation and gene expression across treatment and control groups using appropriate statistical tests to define significant adipogenic response. Thresholds for marker expression (e.g., adiponectin, UCP-1) and lipid uptake must be established to enable objective hit selection in compound screening campaigns.
Chapters in this video
0:04
Title
1:01
Adipose Stromal Vascular Fraction Isolation
3:07
Isolation of Adipose Tissue Endothelial Cells
6:08
Induction of Adipogenesis in Isolated Endothelial Cells
7:13
Results: CD31+CD34+ have Endothelial Phenotype and Display Depot- and Subject-specific Responses to Adipogenic Induction
8:57
Conclusion
